Author

Aaliyah Battle

Albert Einstein College of MedicineORCID 0009-0002-4303-9469Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Aditi ShastriiD· 1 shared Amit K. VermaiD· 1 shared Arnold BolomskyiD· 1 shared Björn HäupliD· 1 shared Callie K. VanWinkleiD· 1 shared Elizabeth HilliD· 1 shared Ellen AngelesiD· 1 shared Imit KauriD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aditi ShastriORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyLeukemiaPeer-reviewedSep 28, 2026

Exploiting an Epigenetic Resistance Mechanism to PI3 Kinase Inhibition in Leukemic Stem Cells

Shira G. Glushakow-Smith, Imit Kaur, Simone Sidoli…·Kira Gritsman

This study identifies a resistance mechanism in AML leukemic stem cells to PI3K inhibition and shows that combining PI3K and EZH1/2 inhibitors overcomes resistance.

DOI 10.1038/s41375-026-03145-4

mousebulk RNA-seq

𝕏 PostBluesky

Cancer BiologyBlood Cancer DiscoveryPeer-reviewedAug 31, 2026

Phosphorylation Protects Oncogenic RAS from LZTR1-Mediated Degradation

Lin Zhang, Arnold Bolomsky, Omar S. Al‐Odat…·Ryan M. Young

This study identifies phosphorylation as a mechanism protecting oncogenic RAS from LZTR1-mediated degradation, with implications for targeting RAS stability in hematologic cancers.

DOI 10.1158/2643-3230.bcd-26-0028

humanproteomics

𝕏 PostBluesky